Clinical Trial Update: Gabapentin for the Reduction of Opiate Use Following Pulmonary Resection (GROUP Trial) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating gabapentin to reduce opiate use after pulmonary resection has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Disease
• Thoracic Disease

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Thoracic, Pulmonary Disease | Phase 3 | Status: WITHDRAWN